BLKB · Blackbaud, Inc. · Stock research

Reference close: $47.52 (2026-08-21), from the split/dividend-adjusted daily series.

BLKB — Blackbaud, Inc.

Current Thesis

The leg being underwritten is unchanged from the 2026-07-29 print: a ~3%-growth vertical-software franchise re-rating on share-count shrinkage rather than on revenue. What has changed in the ten sessions since this note was last advanced is that the post-print consolidation resolved upward instead of decaying. The stock closed $47.52 on 2026-08-21 against $45.45 on 2026-08-11 and $45.87 on 2026-08-07 — the close that carried an RSI(14) reading of 80.1. RSI(14) on 2026-08-21 was 62.8. Momentum cooled by seventeen points while price rose $1.65; that combination retires the prior concern that the August shelf would decay on absent news flow, and it does so without any new company disclosure.

The fundamentals are the same dated set. Q2 FY26 (2026-07-29): GAAP revenue $290.6M, +3.0%; non-GAAP organic revenue +3.0%; recurring revenue $285.3M, +3.3%, at 98.2% of total; adjusted EPS $1.33 versus $1.28 consensus on revenue of $290.597M that missed $292.303M. FY2026 guidance affirmed at $1.173B–$1.179B revenue and $5.15–$5.25 adjusted EPS, with management stating it expects the upper half of its ranges and EPS and free cash flow at the high end. Roughly $850M remained under the December 2025 repurchase authorization at 2026-06-30.

The new constraint is valuation against published targets. As of 2026-08-23 the aggregated consensus average target was $48.50 — about 2% above the 2026-08-21 close. The dispersion behind that average is wide: Stifel Hold with a $30 target (2026-07-10, cut from $45), Evercore ISI In-Line at $48 (2026-07-30), Baird at $54 (2026-07-30), Raymond James Outperform at $55 (2026-07-29), and a Weiss Ratings Sell (D+) dated 2026-08-06. Five covering firms split one sell, two hold, two buy. Price has walked into the middle of that spread with no new sell-side action in the three weeks since 2026-07-30.

The narrative is maturing. The attention event was the 2026-07-29 print and the target resets of 2026-07-29/30. Since then: one 8-K board appointment (2026-08-05), one Form 4 sale (2026-08-06), one marketing release naming the 2026 Impact Awards winners (2026-08-18), and no sell-side conversion. The narrative is known, still working in price, and drawing aggregator attention pieces rather than fresh institutional research. That is a moderating-flow profile, not an accelerating one.

Bullish and bearish views on Blackbaud, Inc.

The model's bull view on Blackbaud, Inc. (BLKB), in brief: Q2 FY26 organic revenue +3.0% (2026-07-29) against a trailing-twelve-month revenue growth rate of 0.7% measured on 2026-08-07 — the quarter clears the trailing rate for the first time in the recent record. The bear view: Insider flow is one-way. EVP and COO Kevin P. Gregoire sold 22,000 shares on 2026-08-06 at weighted average prices of $45.4255 and $45.7231, holding 113,194 shares directly afterwards, with the Rule 10b5-1 checkbox unmarked (Form 4 accepted 2026-08-07). No open-market insider… Both cases follow in full.

Bull Case

• Q2 FY26 organic revenue +3.0% (2026-07-29) against a trailing-twelve-month revenue growth rate of 0.7% measured on 2026-08-07 — the quarter clears the trailing rate for the first time in the recent record.
• Guide affirmed with an explicit upward skew (2026-07-29): FY2026 revenue $1.173B–$1.179B against $1.176B consensus, adjusted EPS $5.15–$5.25 against $5.19, plus upper-half commentary and EPS/FCF at the high end.
• The issuer is the identified marginal buyer: ~$850M left under the repurchase authorization at 2026-06-30, just over 6% of shares retired year-to-date, share count down ~15% since Q4 2023 to 44.72M. Market capitalisation was $2.16B on 2026-08-23, so the residual authorization is a large fraction of the equity.
• Revenue quality supports the buyback arithmetic: 98.2% of Q2 FY26 revenue was recurring, so the cash funding repurchases is subscription-derived rather than order-book dependent.
• Multiple against the tape: trailing P/E 14.85 on 2026-08-23; forward P/E was 8.09 on 2026-08-11 (stockanalysis.com). The 2026-08-21 close of $47.52 sits 32.3% below the $70.17 52-week high.
• Two firms carry targets above the price: Raymond James $55 (2026-07-29) and Baird $54 (2026-07-30).
• Dormant strategic mark: Clearlake Capital's unsolicited all-cash proposal at $80.00 per share, confirmed 2024-04-15 and rejected. Two years stale; no live bid is in evidence.

Bear Case

• Insider flow is one-way. EVP and COO Kevin P. Gregoire sold 22,000 shares on 2026-08-06 at weighted average prices of $45.4255 and $45.7231, holding 113,194 shares directly afterwards, with the Rule 10b5-1 checkbox unmarked (Form 4 accepted 2026-08-07). No open-market insider purchase appears in the same window. Insider ownership stood at 2.01% on 2026-08-23.
• The top line missed. Revenue of $290.597M against $292.303M consensus on 2026-07-29. The beat was on EPS, which a 15% smaller share count flatters mechanically.
• One quarter is not a trend. TTM revenue growth of 0.7% (2026-08-07) sits well under the 3.0% Q2 organic print, and nothing tests the gap until the Q3 report.
• Price has caught the average target. $47.52 (2026-08-21) versus a $48.50 consensus average (2026-08-23) and an Evercore target of $48 set on 2026-07-30. The lowest published target, Stifel's $30, was cut from $45 on 2026-07-10 — after the March–May drawdown that took the stock to a $25.58 52-week low, and before the July print.
• The calendar is empty. No company-scheduled financial event falls between 2026-08-23 and the Q3 FY26 print, which is not yet dated. Q1 FY26 was reported 2026-04-29 and Q2 FY26 on 2026-07-29, both Wednesdays pre-market, implying ~2026-10-28 (est.).
• The move is large and recent. The shares are up 60.7% over the three months to 2026-08-21, so the buyer at current levels is paying for the re-rating, not underwriting it.

Setup & Price Structure

• 2026-08-21 close $47.52; RSI(14) 62.8. Against the 2026-08-07 close of $45.87 at RSI(14) 80.1, momentum has unwound roughly seventeen points while price advanced. The overbought condition cleared through time rather than through a retracement.
• The August shelf is $45.45–$45.87 (closes of 2026-08-11 and 2026-08-07). Weekly closes have held above it, and the week ending 2026-08-21 registered a higher high than the week of 2026-08-07 — the specific stall condition flagged in the prior note did not occur.
• Overhead: the 52-week high is $70.17 on the adjusted series; the 2026-08-21 close is 32.3% below it. Supply between here and there was generated on the way down, so any continuation is a retracement through prior holders rather than a move into clear air.
• Downside reference: the 52-week low of $25.58 was set earlier in the range. A weekly close below $42 would put price back beneath the entire post-print shelf and unwind the re-rating that began 2026-07-29.
• Crowding observables, stated as observables: institutional ownership 94.21% and insider ownership 2.01% (2026-08-23); two insider sales and no insider buys since 2026-06-01; no equity issuance into the move — the company is retiring shares, not printing them; price within ~2% of the consensus average target; no earnings date inside 30 days; and syndicated "why is this getting attention" coverage appearing on retail aggregators in August rather than new dated broker initiations.

Catalyst Calendar (next 30 days)

• No company-dated financial event falls inside the 2026-08-23 to 2026-09-22 window. The most recent company release was the 2026 Impact Awards winners announcement on 2026-08-18, which carries no financial disclosure.
• ~2026-10-28 (est.) — Q3 FY26 results. Date unannounced as of 2026-08-23; the estimate follows the Q1 (2026-04-29) and Q2 (2026-07-29) Wednesday pre-market pattern.

Elapsed catalysts

• ~2026-10 (est.) — press release announcing the Q3 FY26 reporting date. Blackbaud dated its Q1 print by release ahead of 2026-04-29; the equivalent notice fixes the timing of the next test of the FY26 guide. (passed 119d ago)
• ~2026-12 (est.) — possible board action on the repurchase authorization. The program was expanded, replenished and reauthorized in December 2025; a further action would show whether the buyback pace is being extended past the ~$850M residual reported at 2026-06-30. (passed 57d ago)

What Would Change Our Mind

The structure that matters is the shelf built between the 2026-08-07 close of $45.87 and the 2026-08-11 close of $45.45, which has held every weekly close since the print. Losing it in full — a weekly close below $42 — would mean the post-Q2 re-rating has been given back and the buyback bid is no longer setting the marginal price. That is the gradeable break.

Three non-price conditions would do the same work more slowly. First, a trim to the FY26 revenue range of $1.173B–$1.179B, or organic growth printing under 3.0% at the Q3 report (~2026-10-28, est.), would show the Q2 acceleration was a one-quarter artifact against the 0.7% TTM rate. Second, a decelerating share-count reduction in the next 10-Q against the just-over-6% year-to-date pace would break the EPS arithmetic that the affirmed $5.15–$5.25 guide rests on. Third, if the ~9-week catalyst gap closes with price still inside the spread between Stifel's $30 and Raymond James' $55 and no new dated broker action, the classification moves toward saturated — a known story with no incremental bid.

The condition that would strengthen the read rather than break it: a new Buy-rated initiation or a target reset above $55, or an open-market insider purchase reversing the 2026-06-01 and 2026-08-06 sales.

Correlation Notes

• End-market, not AI capex. Revenue comes from nonprofit, faith, K-12 and higher-education budgets. The name does not track hyperscaler capex or GPU supply, so it is a poor hedge and a poor proxy for the AI-infrastructure complex; the software-multiple correlation runs through rates and small-cap risk appetite instead.
• Buyback cohort. With no dividend, the whole shareholder return runs through repurchases, which ties the stock to the small-cap buyback factor rather than to any yield-proxy bid.
• Sponsor-M&A sentiment. The 2024-04-15 Clearlake proposal at $80.00 left a residual take-private option in the story. Renewed take-private activity in vertical SaaS tends to lift the whole cohort's floor multiple; the reverse also holds.
• Liquidity profile. 44.72M shares outstanding against a $2.16B market capitalisation (2026-08-23) and 94.21% institutional ownership leave a small effective float, so index rebalances and single large holders can move price independently of news.